Factor II Mutation Screening F2 - G20210A Test sale cost 1200 AED
Immune Deficiency Panel 1 Test sale cost 1450 AED Immune Deficiency Panel 1 Test Cost 1,610 د.إ Original price was: 1,610 د.إ.1,450 د.إCurrent price is: 1,450 د.إ.
Ganglioside GD1a Antibody IgG Test sale cost 1420 AED Ganglioside GD1a Antibody IgG Test Cost 1,570 د.إ Original price was: 1,570 د.إ.1,420 د.إCurrent price is: 1,420 د.إ.
Sale!

Factor II Mutation Screening F2 – G20210A Test Cost

Original price was: 1,600 د.إ.Current price is: 1,200 د.إ.

-25%

The Factor II Mutation Screening F2 – G20210A Test is a specialized genetic test offered by DNA Labs UAE, designed to identify the presence of the G20210A mutation in the F2 gene. This mutation is associated with an increased risk of developing blood clots, including conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE), which can have serious health implications. By detecting this mutation, individuals can take preventive measures or seek early treatment to manage their risk effectively.

The test is conducted through a simple blood sample, utilizing advanced genetic analysis techniques to accurately identify the presence of the G20210A mutation. The cost of the test is set at 1200 AED, making it accessible for individuals who are at risk or have a family history of blood clotting disorders. DNA Labs UAE is known for its reliable and accurate genetic testing services, providing patients and healthcare providers with crucial information for managing health and preventing complications associated with the Factor II mutation.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Factor II Mutation Screening F2 – G20210A Test

Test Name: FACTOR II Mutation Screening F2 – G20210A Test

Components: EDTA Vacutainer (2ml)

Price: 1200.0 AED

Sample Condition: Peripheral blood

Report Delivery: 3-4 days

Method: End Point PCR + RFLP

Test Type: Genetics

Doctor: Oncology

Test Department: Pre Test Information

FACTOR II Mutation Screening (F2 – G20210A) can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Factor II mutation screening, also known as F2 – G20210A mutation screening, is a genetic test that checks for a specific mutation in the Factor II gene. This mutation, known as the G20210A mutation, is associated with an increased risk of developing blood clots, particularly in the veins (venous thromboembolism).

The Factor II gene provides instructions for making a protein called prothrombin, which plays a crucial role in the blood clotting process. The G20210A mutation involves a change in the DNA sequence of the Factor II gene, resulting in increased levels of prothrombin in the blood. This elevated prothrombin level can lead to an increased tendency for blood clot formation.

Factor II mutation screening is typically performed in individuals with a personal or family history of blood clots, particularly at a young age or in unusual locations. It may also be recommended for individuals with a history of recurrent miscarriages, as the mutation has been associated with an increased risk of pregnancy complications.

The screening test involves analyzing a blood sample for the presence of the G20210A mutation. If the mutation is detected, it can help guide treatment and management decisions, such as the use of blood thinning medications to prevent clot formation.

It is important to note that not all individuals with the Factor II mutation will develop blood clots, and other genetic and environmental factors also play a role in determining an individual’s risk. Therefore, the test results should be interpreted in conjunction with other clinical information to assess an individual’s overall risk of clotting disorders.

Test Name FACTOR II Mutation Screening F2 – G20210A Test
Components EDTA Vacutainer (2ml)
Price 1200.0 AED
Sample Condition Peripheral blood
Report Delivery 3-4 days
Method End Point PCR + RFLP
Test type Genetics
Doctor Oncology
Test Department:
Pre Test Information FACTOR II Mutation Screening (F2 – G20210A) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Factor II mutation screening, also known as F2 – G20210A mutation screening, is a genetic test that checks for a specific mutation in the Factor II gene. This mutation, known as the G20210A mutation, is associated with an increased risk of developing blood clots, particularly in the veins (venous thromboembolism).

The Factor II gene provides instructions for making a protein called prothrombin, which plays a crucial role in the blood clotting process. The G20210A mutation involves a change in the DNA sequence of the Factor II gene, resulting in increased levels of prothrombin in the blood. This elevated prothrombin level can lead to an increased tendency for blood clot formation.

Factor II mutation screening is typically performed in individuals with a personal or family history of blood clots, particularly at a young age or in unusual locations. It may also be recommended for individuals with a history of recurrent miscarriages, as the mutation has been associated with an increased risk of pregnancy complications.

The screening test involves analyzing a blood sample for the presence of the G20210A mutation. If the mutation is detected, it can help guide treatment and management decisions, such as the use of blood thinning medications to prevent clot formation.

It is important to note that not all individuals with the Factor II mutation will develop blood clots, and other genetic and environmental factors also play a role in determining an individual’s risk. Therefore, the test results should be interpreted in conjunction with other clinical information to assess an individual’s overall risk of clotting disorders.

SKU: TEST-5354